DPP4 and type 2 diabetes mellitus: Sitagliptin, an absorbable DPP4 inhibitor, was found to retard the progression of carotid atherosclerosis in T2DM patients29,30 and ApoE-deficient mice31,32 by improving endothelial function and imparting anti-inflammatory effects.